What Happened?
Little Rock, AR-based InterveXion-Therapeutics Appointed Keith Ward as President and Chief Executive Officer
About the Company
At InterveXion we develop novel products for the treatment of addiction disorders. Since our founding in 2004, our team has been dedicated to providing therapeutic options for patients suffering from the debilitating effects of addiction. We occupy office and laboratory space in the BioVentures Building on the campus of the University of Arkansas for Medical Sciences (UAMS), from whom we licensed our lead technology.
About the Person
Keith Ward is President and Chief Executive Officer at InterveXion Therapeutics. Previously, Keith held various senior HR leadership roles in the industry.
Info Source
News
Short Profile